glp-1 agonists australia Supporting patients through agonist cessation effects Glucagon-like peptide-1 receptor agonists –

And does it work better for weight loss than Ozempic and Wegovy

Antidiabetes agents and incident depression: a nationwide population-based study

Diabetes 60(12):31033109 Yanagimachi T, Fujita Y, Takeda Y et al (2016) Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (130) expression is upregulated in diabetes and PEGylated GIP(130) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice

94 The six lysine residues increase the rigidity of the molecules structure, thus allowing its drug properties to be improved

A meta-analysis of seven placebo-controlled cardiovascular outcomes trials found no increased risk of either acute pancreatitis or pancreatic cancer with GLP-1 RA treatment (Peto OR: 1.05, 95% CI 0.78, 1.40), 70 providing reassurance evidence against this concern in high-risk populations